WEBULL
WebtradeDownload

Learn Why The Bull Case For AXT (AXTI) Could Change Following S&P 600 Addition

Simply Wall St · 1d ago
  • AXT was recently added to the S&P 600 index, increasing its visibility among institutional investors, while its indium phosphide substrates gain attention in co packaged optics.
  • The same material that positions AXT in high speed data connectivity is now tied more closely to index linked capital flows and portfolio mandates.
  • We will now see how AXT's addition to the S&P 600 could influence the broader investment narrative around its substrate business.

Scan for other suppliers riding the same data connectivity wave as AXT by checking the curated 87 AI infrastructure stocks that focus on the hardware behind AI and high speed networking.

AXT Investment Narrative Recap

To own AXT, you need to be comfortable with a very focused bet on compound semiconductor substrates tied to high speed data and AI connectivity. The near term story still hinges on indium phosphide demand translating into better factory utilization and cleaner gross margins, not just higher trading volumes after the S&P 600 move.

The biggest operational swing factor remains export permit reliability and customer concentration in China, which can disrupt shipments and cash flow. Index inclusion does not change that risk. It mainly adds more attention to how AXT manages its operations and finances while it works to turn forecast revenue growth into sustained profitability, with volatility in its germanium and gallium arsenide lines an additional consideration.

The most relevant part of the recent news is the spotlight on AXT’s indium phosphide role in co packaged optics. That product is closely tied to a key factor many investors monitor, which is whether AI and data center demand for higher speed optical links leads to stable, higher quality substrate orders.

Index addition and sector attention can sharpen scrutiny on execution. For you as a shareholder, the focus still comes back to a few basics. Does AXT convert that interest into longer term contracts? Does it improve margins from the current low levels? And can it do that while export rules, costs and customer concentration remain significant sources of risk?

What The AXT Analyst Scenario Implies

AXT's story in the analyst models is built on unusually aggressive expansion in both revenue and profitability. Those forecasts call for revenue to rise at 93.7% a year over the next three years and for net margin to move from 3.1% today to 39.6% in three years. On earnings, the consensus points to a move from $3.9 million today to $360.8 million by 2029, which is a very large step up in profit.

AXT's narrative projects $911.9 million revenue and $360.8 million earnings by 2029. This setup assumes 93.7% yearly revenue growth and a very large earnings increase from $3.9 million today.

Those same estimates sit behind the current P/E assumptions in the report. The stock is described as trading on a P/E of 1,116.9x today, with the consensus framework using a future multiple of 27.5x on those 2029 earnings. That future P/E is below the 45.1x figure quoted for the broader US semiconductor group in the report, which indicates that analysts are not assigning a premium multiple on top of the big profit ramp they already expect.

On the top line, the forecast points to revenue of $911.9 million in 2029 paired with earnings of $360.8 million in that same year. The numbers imply a very high implied margin profile by the end of the forecast window, well above where AXT operates today. For you as an investor, the key question is whether a substrate supplier with exposure to export permits, customer concentration and volatile gross margins can support that profit structure over time.

Price targets in the report offer a range rather than a single figure to anchor on. The consensus target sits at $91.60 per share, with the most optimistic analyst at $125.00 and the most cautious at $55.00. With a current share price of $67.45 referenced in the analysis, the midpoint implies a 26.4% gap to that target, but the spread between the high and low views shows how different the outcomes could be if export rules, AI hardware spending or factory utilization develop differently from the base case.

The discount rate of 11.3% used in the model is also worth keeping in mind. That figure, along with the projected P/E of 27.5x in 2029, shapes what the report calls "fair value" for AXT. If your own assumptions on risk, required return or margin structure differ meaningfully from those inputs, your view on what counts as a reasonable price could sit well above or well below the consensus range.

For anyone holding or tracking AXT, the practical takeaway is simple. The analyst framework leans on very strong compounding in revenue, a dramatic shift in profitability, and a normalizing valuation multiple. Your task is to test each of those moving parts against your own expectations for indium phosphide demand, export policy stability and the firm's ability to keep lifting utilization and margins in germanium and gallium arsenide through 2029.

Uncover why AXT's fair value indicates a 15% potential upside to its current price that could narrow quickly.

NasdaqGS:AXTI 1-Year Stock Price Chart
NasdaqGS:AXTI 1-Year Stock Price Chart

Exploring Other Perspectives

The lowest analysts lean hard on export permit risk. They assume AXT reaches about US$781.7 million of revenue and US$324.3 million of earnings by 2029, which is still sizable but below the consensus path. After the S&P 600 inclusion and co packaged optics attention, those more cautious forecasts may shift, so explore both narratives before deciding where you stand.

Explore 4 other AXT fair value estimates, including one that suggests as much as 98% downside from the current price.

Reach Your Own Conclusion

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Investment Ideas Beyond AXT?

If AXT has sharpened your interest in how specific technologies connect to long term financial outcomes, it can help to line that story up against other opportunities. Use the Simply Wall St Screener to compare different types of stocks side by side and see which profiles better match your risk tolerance and return goals.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.